# Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL.

> **NCT01670370** · PHASE2 · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Diffuse Large B-cell Lymphoma

## Interventions

- **DRUG:** R-GemOx

## Key facts

- **NCT ID:** NCT01670370
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-08
- **Primary completion:** 2015-12
- **Final completion:** 2019-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01670370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01670370, "Trial of R-GemOx Regimen in Previously Untreated Elderly Patients With DLBCL.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01670370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*